Literature DB >> 1333572

Varicella-zoster virus encephalitis in acquired immunodeficiency syndrome: report of four cases.

F Gray1, M Mohr, F Rozenberg, L Belec, M C Lescs, E Dournon, E Sinclair, F Scaravilli.   

Abstract

Four patients with acquired immunodeficiency syndrome, a 27-year-old female intravenous drug abuser and three males (two drug addicts aged 27 and 33 years and a 40-year-old homosexual) presented with a rapidly progressive encephalopathy. Two had generalized varicella-zoster virus skin infection, one had had a regressive thoracic zoster rash 7 months previously and one had no history of cutaneous eruption. Neuropathological examination revealed, in each case, multifocal necrotic changes with numerous, intranuclear Cowdry type A inclusion bodies in glial cells, endothelial cells, macrophages and neurons, within and around the lesions. These inclusion bodies were stained positively for varicella-zoster virus by immunocytochemistry and contained herpes virus nucleocapsids by electron microscopy. Molecular biology using the polymerase-chain-reaction method demonstrated viral genome. In one case, zoster-induced non-inflammatory vasculopathy involved medium sized leptomeningeal vessels and was associated with circumscribed areas of cortico-subcortical infarction. In another case, varicella-zoster virus encephalitis was associated with human immunodeficiency virus encephalitis and a secondary cerebral lymphoma. Multinucleated giant cells expressing human immunodeficiency virus proteins in their cytoplasm, were found in the lymphomatous deposits and in the varicella-zoster virus necrotic lesions. In these latter lesions, Cowdry type A inclusion bodies could be seen in the nuclei of some multinucleated giant cells confirming previous observations of MGCs co-infected by HIV and CMV, and supporting the hypothesis that DNA viruses interact with HIV, thus increasing its effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333572     DOI: 10.1111/j.1365-2990.1992.tb00817.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

1.  Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid.

Authors:  Iñigo Corral; Carmen Quereda; Antonio Antela; Vicente Pintado; José Luis Casado; Pilar Martín-Dávila; Enrique Navas; Santiago Moreno
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  Association of progressive outer retinal necrosis and varicella zoster encephalitis in a patient with AIDS.

Authors:  G J van den Horn; C Meenken; D Troost
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

Review 3.  Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Lancet Neurol       Date:  2009-08       Impact factor: 44.182

Review 4.  Response to acyclovir in two cases of herpes zoster leukoencephalitis and review of the literature.

Authors:  J Otero; E Ribera; J Gavaldà; A Rovira; I Ocaña; A Pahissa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

5.  Acute varicella-zoster virus ventriculitis and meningo-myelo-radiculitis in acquired immunodeficiency syndrome.

Authors:  F Chrétien; F Gray; M C Lescs; C Geny; M L Dubreuil-Lemaire; F Ricolfi; M Baudrimont; Y Levy; A Sobel; H V Vinters
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 6.  Varicella zoster virus vasculopathy: clinical features and pathogenesis.

Authors:  Maria A Nagel
Journal:  J Neurovirol       Date:  2013-08-06       Impact factor: 2.643

Review 7.  Virus vasculopathy and stroke: an under-recognized cause and treatment target.

Authors:  M A Nagel; R Mahalingam; R J Cohrs; D Gilden
Journal:  Infect Disord Drug Targets       Date:  2010-04

Review 8.  Infectious diseases of the central nervous system.

Authors:  Danièlle Gunn-Moore
Journal:  Vet Clin North Am Small Anim Pract       Date:  2005-01       Impact factor: 2.093

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.